Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Inhalation Aerosol in Persistent Asthma
NCT00116103Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2005
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus in asthma, sponsored by Astellas Pharma. Started Jun 2005; status: completed.
02
Drugs
tacrolimus
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00116103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116103.